+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

ISHLT Research Fellowship Grant

International Society for Heart & Lung Transplantation

The ISHLT Research Fellowship Grant is designed to support trainees pursuing basic, clinical, or translational research in the fields of advanced heart or lung disease, transplantation, mechanical circulatory support, or pulmonary vascular disease (PVD). This funding aims to foster the development of trainees and promote innovative research that advances the science and care of patients in these areas.

Purpose

The ISHLT Research Fellowship Grant will fund an innovative project led by a trainee that advances research in the fields of advanced heart or lung disease, transplantation, mechanical circulatory support, and/or pulmonary vascular disease (PVD). Proposals may involve basic science, clinical, or translational research.

Grant Details

One grant of up to $40,000 USD will be awarded for one year.

Funding Stipulations / Grant Policies

Please review these guidelines and terms prior to completing your application. If you are ultimately awarded a grant, you will sign a letter of agreement (LOA) stating that you agree to these funding guidelines and terms, and the LOA will be co-signed by your institution’s grant/research office.

Research is anticipated to begin within six months of the grant being awarded.
Funding in the amount of up to $40,000 USD will be provided for the research project.
Funding will not be released until visa status is confirmed (if applicable).
The grant is intended to fund salary support for the researcher, other study personnel, statistical support, supplies/materials, core facility use, animals, participant honoraria, publication costs and travel related costs for abstract presentation. Up to 10 percent of the grant can be used for institutional overhead. No other costs are permitted.
The grant will be paid in multiple installments to the recipient's institution. First installment (50% of funds) will be paid at the beginning of grant work; the second installment (25%) will be paid mid-award (after receipt of a grant progress report) and the final installment (25%) will be paid after receipt of a final report.
Grant funding is not transferable from one recipient to another. If the grantee relocates and requests to move the grant to the new institution, the Grants Committee will determine if the grant can be transferred or must be surrendered and any remaining funds returned. A transfer request should be submitted in writing. If the grant is surrendered, a final report will still be required.
The applicant must acknowledge the grant as a funding source in all manuscripts and presentations derived from the funded research using the following statement: “This work was supported by a grant from the International Society for Heart and Lung Transplantation supported by the ISHLT Foundation.” Copies of such publications must be submitted to ISHLT.
Pursuant to regulations of the federal Physician Payment Sunshine Act (included in the Affordable Care Act), NPI numbers will be collected from grant recipients (if applicable), and tax ID numbers collected from the recipients' institutions (if applicable). All payments will be reported to the Centers for Medicare and Medicaid Services Open Payments system, as payments from ISHLT represent indirect transfers of value from the funding pharmaceutical company.
Reports are required at the following intervals depending on the term of the grant, and continuation of funding is contingent upon completion of these reports :
1. Mid-award progress report due six months after funding begins.
2. Final report within 30 days of the conclusion of the grant term. A final report is required even if the grant is surrendered for any reason prior to the conclusion of the grant term.

AI based application success predictor

1) Match to ISHLT mission + the specific grant’s scope

Projects that clearly advance transplantation, mechanical circulatory support, and innovative therapies (and the particular grant topic area) tend to do better.

2) Strong “score drivers”: significance + novelty + feasibility

ISHLT’s Innovation Challenge–type mechanisms explicitly score things like:

Novelty

Research approach

Feasibility of obtaining relevant data

Prior work (evidence you can execute)
(And some programs also list significance/innovation directly.)

In practice, this translates to: a tight question, a doable plan, and credible proof you can deliver (pilot data, access to patients/samples/registry, realistic recruitment).

3) “Prior work” that reduces reviewer risk

Even when a grant is aimed at early investigators, reviewers still want to see:

a track record in the area (papers/abstracts, prior related projects), or

a mentor/team with that track record + your clear role
ISHLT specifically names prior work as part of scoring (for some grants), so having concrete preliminary outputs helps.

4) Mentor + environment that make success inevitable (especially for fellowships)

For trainee/fellowship-style awards, ISHLT requires the applicant and mentor/project director to be members by a stated deadline, and the applicant must truly be in a trainee role (not faculty-level). That structure signals what reviewers value: a real training plan + committed mentor + resources.

5) Clean, fundable proposal mechanics

ISHLT notes proposals are reviewed for scientific merit and fundability by multiple reviewers (and sometimes outside experts).
So “fundable” tends to mean:

specific aims that aren’t overly broad

methods/statistics that match the question

realistic timeline and milestones

budget that is tight and justified

6) Eligibility and membership: don’t give reviewers an easy reason to toss it

Many ISHLT grants require ISHLT membership in good standing (sometimes by a deadline) and other role-specific eligibility (e.g., nursing/allied health restrictions for the Nursing Research Grant).

Specialties

Cardiothoracic Surgery

Pulmonology

Cardiovascular Diseases

Transplant Surgery

Eligibility Requirements

Academic Appointment and Institutional Resources

The applicant must be a trainee who will not have a faculty level appointment (Assistant Professor equivalent or above) or salaried senior staff position (or equivalent) during the period of the grant.

ISHLT Membership

The applicant and the applicant's mentor/research project director must be members of the ISHLT by January 20, 2026.

Previous ISHLT Funding/Funding from Other Sources

There are no restrictions on past or current funding.
If the applicant is currently receiving funding for a project similar to the topics described in this application, the applicant must explain how the funds of the grant would not overlap with the funds of the other research support.

Sponsor Details

Sponsor Institute/Organizations: International Society for Heart & Lung Transplantation

Sponsor Type: Corporate/Non-Profit

Address: 141 West Jackson Suite 1340 Chicago, IL 60604 USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity